Skip to content

Prime Medicine PRME Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
895.9M-0.5%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
256.3M-1.2%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
118.5M+14.5%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
96.1M+11.8%
Beam Therapeutics logo
Beam TherapeuticsBEAM
103.3M+17.4%
Regenxbio logo
RegenxbioRGNX
52.4M+1.9%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's shares (diluted)?
Prime Medicine (PRME) reported shares (diluted) of 177.1M in Q1 2026.
How has Prime Medicine's shares (diluted) changed year-over-year?
Prime Medicine's shares (diluted) increased by 35.3% year-over-year, from 130.9M to 177.1M.
What is the long-term trend for Prime Medicine's shares (diluted)?
Over 3 years (2022 to 2025), Prime Medicine's shares (diluted) has grown at a 81.4% compound annual growth rate (CAGR), from 95.4M to 569.3M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.